NeuroBo Pharmaceuticals, Inc. Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • NeuroBo Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -122 %, a 212% decline year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2023 was -45.4 %, a 47.5% increase from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2022 was -86.4 %, a 29.7% increase from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2021 was -123 %, a 47% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -45.4 +41 +47.5% Jan 1, 2023 Dec 31, 2023
2022 -86.4 +36.4 +29.7% Jan 1, 2022 Dec 31, 2022
2021 -123 +109 +47% Jan 1, 2021 Dec 31, 2021
2020 -232 +87.8 +27.5% Jan 1, 2020 Dec 31, 2020
2019 -319 -252 -375% Jan 1, 2019 Dec 31, 2019
2018 -67.3 +69 +50.6% Jan 1, 2018 Dec 31, 2018
2017 -136 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.